Form 4: Novanta Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Novanta Inc. Director Thomas N Secor sold 748 shares of common stock for $119.67 per share under a pre-established 10b5-1 trading plan.
Summary
- Thomas N Secor, a Director of Novanta Inc. (NOVT), disposed of 748 shares of common stock.
- The transaction occurred on December 15, 2025, at a price of $119.67 per share.
- The sale was executed pursuant to a pre-established Rule 10b5-1 trading plan adopted by Mr. Secor on September 10, 2025.
- Following this transaction, Mr. Secor beneficially owns 747 shares of Novanta Inc. common stock directly.
Sentiment
Score: 5
Explanation: Neutral, as the transaction was a pre-planned sale under a Rule 10b5-1 plan, which typically indicates a non-discretionary sale for personal financial management rather than a signal of future company performance or a change in management's outlook.
Future Outlook
NA
Industry Context
This is an insider transaction report, which provides specific details about a director's stock activity. It does not inherently provide broader industry context or trends, but rather reflects individual executive financial planning.
Stakeholder Impact
- Shareholders: The sale by a director, even under a 10b5-1 plan, slightly reduces insider ownership. While pre-planned, some investors may monitor insider selling as a general indicator, though this specific transaction is relatively small.
Key Dates
| Date | Description |
|---|---|
| 09/10/2025 | Rule 10b5-1 trading plan adopted by the reporting person. |
| 12/15/2025 | Date of transaction (sale of common stock). |
| 12/17/2025 | Date of Form 4 filing. |
Recommendation
holdThe sale of 748 shares by Director Thomas N Secor was executed under a pre-established Rule 10b5-1 trading plan, indicating a non-discretionary transaction for personal financial planning rather than a reflection of a change in the company's fundamental outlook. Given the relatively small number of shares sold and the pre-planned nature, this event alone does not warrant a change in investment recommendation. Investors should continue to evaluate Novanta Inc. based on its operational performance and broader market conditions.
Keywords
Novanta Inc., NOVT, Insider Trading, Form 4, Stock Sale, Director, 10b5-1 Plan, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.